Pillar Pharmaceuticals II, L.P., 10% Owner at IDERA PHARMACEUTICALS, INC. (IDRA), sold 2,500,000 shares at $1.92 ($4.9M) on 2017-12-13, disclosed to the SEC on 2017-12-15.
Open-market sale of $4.9M IDRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.92 | 500,000 | $960K | 19.5% |
| 2 | $1.93 | 600,000 | $1.2M | 23.6% |
| 3 | $2.00 | 300,000 | $600K | 12.2% |
| 4 | $2.00 | 700,000 | $1.4M | 28.5% |
| 5 | $2.01 | 166,170 | $334K | 6.8% |
| 6 | $2.01 | 166,170 |
| $334K |
| 6.8% |
| 7 | $1.91 | 33,830 | $65K | 1.3% |
| 8 | $1.91 | 33,830 | $65K | 1.3% |
| Total | $1.97 avg | 2,500,000 | $4.9M | 100% |
| Filing → |
| IDRA | SELL | 2017-05-03 | $2.0M | — | Filing → |